Your Messages Inbox
Your Article Summary
See Latest ArticlesAlcon Announces AZARGA Ophthalmic Suspension Approved for Treatment of Patients with Glaucoma or Ocular Hypertension in the European Union
Alcon, 01/13/09
Alcon, Inc. announced that the European Medicines Agency (EMEA) has approved Alcon's fixed combination eye drop, AZARGA (brinzolamide 10mg/ml+timolol 5mg/ml) ophthalmic suspension, for treatment of elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension in adult patients for whom monotherapy provides insufficient IOP reduction.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Multaq Approved in the European Union for Patients with Atrial Fibrillation
Sanofi-aventis, 12/01/09
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS
BioMarin, 12/01/09
Article Search
Sponsor